MedTrace Logo

Resistant Starch, Gut Bacteria and Diabetes

NCT03057444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-10-26

No results posted yet for this study

Summary

The aim of the study is to investigate, if resistant starch type III increases butyrate-producing bacteria in the gut of (pre-) diabetic subjects. Diabetic blood parameters are also of interest.

Conditions

  • Diabetes Mellitus, Type 2
  • Pre Diabetes

Interventions

DIETARY_SUPPLEMENT

SymbioIntest

The intervention is 2x 5g per day the food supplement SymbioIntest (resistant starch types III) over 8 weeks.

Sponsors & Collaborators

  • Institut für Mikroökologie GmbH

    collaborator UNKNOWN

  • University of Hohenheim

    lead OTHER

Principal Investigators

  • Stephan C. Bischoff, Prof. · University of Hohenheim, 70599 Stuttgart

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03057444 on ClinicalTrials.gov